These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 15536684)
21. Caspofungin versus liposomal amphotericin B for empirical therapy. Kontoyiannis DP; Lewis RE N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15673808 [No Abstract] [Full Text] [Related]
22. Caspofungin: the first of a new class of antifungal agents. Valgus JM Cancer Pract; 2001; 9(6):314-6. PubMed ID: 11879335 [No Abstract] [Full Text] [Related]
23. Comparison of caspofungin and amphotericin B for invasive candidiasis. Mora-Duarte J; Betts R; Rotstein C; Colombo AL; Thompson-Moya L; Smietana J; Lupinacci R; Sable C; Kartsonis N; Perfect J; N Engl J Med; 2002 Dec; 347(25):2020-9. PubMed ID: 12490683 [TBL] [Abstract][Full Text] [Related]
24. Trichosporon asahii. Blood-stream infection in a non-cancer patient receiving combination antifungal therapy. O'Gorman C; McMullan R; Webb CH; Bedi A Ulster Med J; 2006 Sep; 75(3):226-7. PubMed ID: 16964817 [No Abstract] [Full Text] [Related]
25. Invasive candidiasis in cancer patients: observations from a randomized clinical trial. DiNubile MJ; Hille D; Sable CA; Kartsonis NA J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554 [TBL] [Abstract][Full Text] [Related]
26. An update on the use of antifungal agents. Martinez R J Bras Pneumol; 2006; 32(5):449-60. PubMed ID: 17268750 [TBL] [Abstract][Full Text] [Related]
27. Caspofungin: a review of its use in the treatment of fungal infections. McCormack PL; Perry CM Drugs; 2005; 65(14):2049-68. PubMed ID: 16162025 [TBL] [Abstract][Full Text] [Related]
32. [Update on therapy of invasive mycoses in hematology and oncology]. Maschmeyer G; Haas A; Böhme A Dtsch Med Wochenschr; 2005 Jun; 130(22):1381-4. PubMed ID: 15915381 [No Abstract] [Full Text] [Related]
33. Caspofungin for invasive fungal infections: combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation. Pancham S; Hemmaway C; New H; Albert E; Dokal I; Roberts IA; McCloy M Pediatr Transplant; 2005 Apr; 9(2):254-7. PubMed ID: 15787803 [TBL] [Abstract][Full Text] [Related]
34. Caspofungin in combination with amphotericin B against Candida glabrata. Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570 [TBL] [Abstract][Full Text] [Related]
35. The echinocandins. Cappelletty D; Eiselstein-McKitrick K Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149 [TBL] [Abstract][Full Text] [Related]
36. Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials. Falagas ME; Ntziora F; Betsi GI; Samonis G Int J Antimicrob Agents; 2007 Feb; 29(2):136-43. PubMed ID: 17207609 [TBL] [Abstract][Full Text] [Related]
37. Use of newer antifungal therapies in clinical practice: what do the data tell us? Perfect JR Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178 [TBL] [Abstract][Full Text] [Related]
39. Micafungin (Mycamine) for fungal infections. Med Lett Drugs Ther; 2005 Jun; 47(1211):51-2. PubMed ID: 15961968 [TBL] [Abstract][Full Text] [Related]
40. A comparative evaluation of properties and clinical efficacy of the echinocandins. Kim R; Khachikian D; Reboli AC Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]